RxDoctor Payments Data

Deepak Reddy, MD

Orthopaedic Surgery of the Spine · South Bend, INNPI 1710119540

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (46.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Globus Medical accounts for 62.6% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2022 at $159,752 and has fallen 60.6% since, to $62,966 in 2025.

$496,307in general payments, 2019–2025

Across 755 payments — averaging $657.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$311K
  • Zimvie Inc.$43K
  • Stryker$42K
  • Si-bone, Inc.$19K
  • Medical Device Business Services, Inc.$18K
  • Kuros Biosciences USA, Inc$11K
  • plus $52K from 31 others

What the payments were for

  • Consulting fees$231,89147%
  • Speaking & faculty fees$154,66331%
  • Travel & lodging$84,95417%
  • Food & beverage$20,1504%
  • Education$4,6501%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$496,307 in reported general payments places this provider in the 85th percentile of 48 orthopaedic surgery of the spine providers in Indiana.

See all orthopaedic surgery of the spine providers in Indiana

Medicare billing

Part B allowed, 2024
$200,570
Medicare patients
243
Services billed
1,168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen53$628
Cyclobenzaprine Hcl57$256
Methylprednisolone23$194
Gabapentin25$189
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$118
Tramadol Hcl16$41
Diazepam12$10

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in South Bend

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →